Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business ("DDS") and welcomes KKR as joint shareholder
/PRNewswire/ -- Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business...
Source: prnewswire.com